Glucocorticoids in Vivo Induce Both Insulin Hypersecretion and Enhanced Glucose Sensitivity of Stimulus-Secretion Coupling in Isolated Rat Islets

Instituto de Bioingeniería, and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Universidad Miguel Hernández de Elche, Elche 03202, Spain.
Endocrinology (Impact Factor: 4.64). 10/2009; 151(1):85-95. DOI: 10.1210/en.2009-0704
Source: PubMed

ABSTRACT Although glucocorticoids are widely used as antiinflammatory agents in clinical therapies, they may cause serious side effects that include insulin resistance and hyperinsulinemia. To study the potential functional adaptations of the islet of Langerhans to in vivo glucocorticoid treatment, adult Wistar rats received dexamethasone (DEX) for 5 consecutive days, whereas controls (CTL) received only saline. The analysis of insulin release in freshly isolated islets showed an enhanced secretion in response to glucose in DEX-treated rats. The study of Ca(2+) signals by fluorescence microscopy also demonstrated a higher response to glucose in islets from DEX-treated animals. However, no differences in Ca(2+) signals were found between both groups with tolbutamide or KCl, indicating that the alterations were probably related to metabolism. Thus, mitochondrial function was explored by monitoring oxidation of nicotinamide dinucleotide phosphate autofluorescence and mitochondrial membrane potential. Both parameters revealed a higher response to glucose in islets from DEX-treated rats. The mRNA and protein content of glucose transporter-2, glucokinase, and pyruvate kinase was similar in both groups, indicating that changes in these proteins were probably not involved in the increased mitochondrial function. Additionally, we explored the status of Ca(2+)-dependent signaling kinases. Unlike calmodulin kinase II, we found an augmented phosphorylation level of protein kinase C alpha as well as an increased response of the phospholipase C/inositol 1,4,5-triphosphate pathway in DEX-treated rats. Finally, an increased number of docked secretory granules were observed in the beta-cells of DEX animals using transmission electron microscopy. Thus, these results demonstrate that islets from glucocorticoid-treated rats develop several adaptations that lead to an enhanced stimulus-secretion coupling and secretory capacity.

Download full-text


Available from: Alex Rafacho, May 15, 2015
1 Follower
  • Source
    • "Additionally, ob/ob islets displayed higher glucose-induced ψm hyperpolarization, further supporting an enhanced β-cell mitochondrial performance in obese mice. All these findings are in agreement with previous reports showing similar metabolic responses in a rat model of insulin resistance (Rafacho et al., 2010). Since enhanced NAD(P)H production and Ψm hyperpolarization should be coupled to increased ATP synthesis (Quesada et al., 2006), the mitochondrial responses in ob/ob islets and their higher glucose sensitivity may explain the electrical activity at lower glucose levels compared with controls (Fig. 3). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is associated with insulin resistance and is known to be a risk factor for type-2 diabetes. In obese individuals, pancreatic beta-cells try to compensate for the increased insulin demand in order to maintain euglycemia. Most studies have reported that this adaptation is due to morphological changes. However, the involvement of beta-cell functional adaptations in this process needs to be clarified. For this purpose, we evaluated different key steps in the glucose-stimulated insulin secretion (GSIS) in intact islets from female ob/ob obese mice and lean controls. Obese mice showed increased body weight, insulin resistance, hyperinsulinemia, glucose intolerance and fed hyperglycemia. Islets from ob/ob mice exhibited increased glucose-induced mitochondrial activity, reflected by enhanced NAD(P)H production and mitochondrial membrane potential hyperpolarization. Perforated patch-clamp examination of beta-cells within intact islets revealed several alterations in the electrical activity such as increased firing frequency and higher sensitivity to low glucose concentrations. A higher intracellular Ca(2+) mobilization in response to glucose was also found in ob/ob islets. Additionally, they displayed a change in the oscillatory pattern and Ca(2+) signals at low glucose levels. Capacitance experiments in intact islets revealed increased exocytosis in individual ob/ob beta-cells. All these up-regulated processes led to increased GSIS. In contrast, we found a lack of beta-cell Ca(2+) signal coupling, which could be a manifestation of early defects that lead to beta-cell malfunction in the progression to diabetes. These findings indicate that beta-cells functional adaptations are an important process in the compensatory response to obesity. Copyright © 2015. Published by Elsevier Ireland Ltd.
    Molecular and Cellular Endocrinology 01/2015; 404(C). DOI:10.1016/j.mce.2015.01.033 · 4.24 Impact Factor
  • Source
    • "Thus, when í µí»½-cells can no longer compensate, a glucolipotoxicity process progressively develops that induces í µí»½cell death accompanied by hypoinsulinemia, hyperglycemia, and hyperlipidemia [15]. The í µí»½-cell compensations [17] can be rapidly obtained experimentally by 5-day treatment with DEX (5 days) [18] [19] that induces peripheral IR [20] [21], which is associated with increased hepatic gluconeogenesis and lipolysis [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glucocorticoid (GC) therapies may adversely cause insulin resistance (IR) that lead to a compensatory hyperinsulinemia due to insulin hypersecretion. The increased íµí»½-cell function is associated with increased insulin signaling that has the protein kinase B (AKT) substrate with 160 kDa (AS160) as an important downstream AKT effector. In muscle, both insulin and AMP-activated protein kinase (AMPK) signaling phosphorylate and inactivate AS160, which favors the glucose transporter (GLUT)-4 translocation to plasma membrane. Whether AS160 phosphorylation is modulated in islets from GC-treated subjects is unknown. For this, two animal models, Swiss mice and Wistar rats, were treated with dexamethasone (DEX) (1 mg/kg body weight) for 5 consecutive days. DEX treatment induced IR, hyperinsulinemia, and dyslipidemia in both species, but glucose intolerance and hyperglycemia only in rats. DEX treatment caused increased insulin secretion in response to glucose and augmented íµí»½-cell mass in both species that were associated with increased islet content and increased phosphorylation of the AS160 protein. Protein AKT phosphorylation, but not AMPK phosphorylation, was found significantly enhanced in islets from DEX-treated animals. We conclude that the augmented íµí»½-cell function developed in response to the GC-induced IR involves inhibition of the islet AS160 protein activity.
    International Journal of Endocrinology 09/2014; 2014. DOI:10.1155/2014/983453 · 1.52 Impact Factor
  • Source
    • "This observation is in agreement with the results obtained with ganglionic antagonist infusion in DEX-induced IR and insulin hypersecretion in human volunteers as described before (Ahrén, 2008). Of note, all these altered ex vivo islet responses are transitory and reversible after discontinuation of GC treatment (Karlsson et al., 2001; Wierup et al., 2006; Rafacho et al., 2010); however, great caution is required in translating these observation to human applications. "
    State of the Art of Therapeutic Endocrinology, 10/2012: chapter 6: pages 121-152; In Tech., ISBN: 978-953-51-0772-9
Show more